People who need emergency care or hospitalization for cannabis use disorder are at an elevated risk of premature death within ...
“So much of our addiction treatment is actively traumatic,” Szalavitz told Salon in a phone interview. “It tells people, ‘Sit ...
Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.
A study published in Nature Mental Health has shed new light on the genetic connection between attention-deficit ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
People using weed for medical purposes are as likely – or more – to become addicted to cannabis as recreational tokers ...
U.S. federal officials have approved a new pain pill aimed at preventing addiction and overdose risks linked to opioids like Vicodin and OxyContin. Journavx (suzetrigine) 50 milligram oral tablets ...
Washington — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ... opioid medicines, a key factor is working to block ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ... risks of opioid medicines, a key factor is working to block pain ...
WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ... of opioid medicines, a key factor is working to block ...